Skip to main content
Technology Transfer Center of the National Cancer Institute
Subscribe

Search form

Menu Search Subscribe
  • Home
  • Available Technologies
  • Partnering with NIH
    • Transactional Agreements
    • Co-Development Agreements
    • License Agreements
    • SBIR Tech Transfer
    • Partnering Events
    • Search NIH portfolio
  • Intellectual Property
    • Inventions
    • Patents
    • Copyright & Publications
    • IP Information for Grantees & Contractors
    • Research Tools and Materials
  • News
  • About TTC
    • Contact TTC
    • Staff Contact Information
    • Vision, Mission, & Role
    • Institutes and Centers Served by TTC
    • Success Stories
    • NCI Technology Transfer Ambassadors Program
    • Employment in TTC
    • TTC Fellowships
    • Training in Technology Transfer
    • Tech Transfer Resources
    • Transition to Industry Fellowship (T2I)

You are here

  • Home
  • Available Technologies
  • Search Technologies
Share:

Product Type

  • Research Tools (1) Apply Research Tools filter

Development Stage

  • Discovery (Lead Identification) (1) Apply Discovery (Lead Identification) filter

Therapeutic Area

  • Immune System and Inflammation (1) Apply Immune System and Inflammation filter
  • Infectious Diseases (1) Apply Infectious Diseases filter

Institutes and Centers

  • NCI - National Cancer Institute (1) Apply NCI - National Cancer Institute filter

Search Technologies

Title (ascending)
Reference Number (ascending)
Start Date (ascending)
Date changed (descending)
Showing 1-1 of 1 results found
  • Infectious Diseases Apply Infectious Diseases filter
  • Discovery (Lead Identification) Apply Discovery (Lead Identification) filter
  • Research Tools Apply Research Tools filter
  • NCI - National Cancer Institute Apply NCI - National Cancer Institute filter
  • Immune System and Inflammation Apply Immune System and Inflammation filter

Novel Fusion Proteins for HIV Vaccine

The National Cancer Institute’s Cancer and Inflammation Program seeks parties to license gp120 and CD4-induced antibody fusion proteins for use in an HIV vaccine.
  • Research Tools
Technology Transfer Center of the National Cancer Institute
  • follow us on LinkedIn
  • follow us on Twitter
  • subscribe via GovDelivery
  • Home
  • Contact Us
  • Disclaimer Policy
  • Accessibility
  • FOIA
  • Site Map
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Cancer Institute
  • USA.gov
NIH … Turning Discovery Into Health®
  • Home
  • Available Technologies
  • Partnering with NIH
    • Transactional Agreements
    • Co-Development Agreements
      • Examples of Co-Development Agreements
      • Co-Development Agreement Process
      • CRADA Payment Options
    • License Agreements
      • Exclusive License Agreements
      • Non-Exclusive License Agreements
      • Start-Up Exclusive License Agreements
      • Licensing Process and Policies
    • SBIR Tech Transfer
    • Partnering Events
      • NCI Start-up 2020
      • 2021 Technology Showcase
      • 2020 Technology Showcase
      • 2019 Technology Showcase
      • 2018 Technology Showcase
      • 2017 Technology Showcase
    • Search NIH portfolio
  • Intellectual Property
    • Inventions
      • Guide for Keeping Laboratory Records: Do's & Don't
      • EIR Review Process
      • Employee Inventor Waivers
      • Inventor Resources
      • NIH Employee Invention Report (EIR)
      • TTC Invention Development Program
    • Patents
    • Copyright & Publications
    • IP Information for Grantees & Contractors
      • IP Sample Plan #1
      • IP Sample Plan #2
      • IP Sample Plan #3
      • IP Sample Plan #4
      • IP Sample Plan #5
      • IP Sample Plan #6
    • Research Tools and Materials
  • News
  • About TTC
    • Contact TTC
    • Staff Contact Information
    • Vision, Mission, & Role
    • Institutes and Centers Served by TTC
    • Success Stories
    • NCI Technology Transfer Ambassadors Program
    • Employment in TTC
    • TTC Fellowships
    • Training in Technology Transfer
    • Tech Transfer Resources
    • Transition to Industry Fellowship (T2I)
Subscribe to our Available Technology Emails:
X